Monitor Dr. Reddy's response to the Form 483 observations and any subsequent USFDA actions (e.g., warning letter, import alert) which could affect the FTO-9 facility's regulatory status and product approvals. No immediate stock-moving catalyst.
Price Chart
Executive Summary
Dr. Reddy's disclosed that the USFDA completed a Pre-Approval Inspection (PAI) at its FTO-9 manufacturing facility in Visakhapatnam from October 8-9, 2026, and issued a Form 483 with three observations. The company stated it will address the observations within the stipulated timeline. This is a routine regulatory update with no material financial impact disclosed.
Key Facts
- USFDA conducted a Pre-Approval Inspection (PAI) at Dr. Reddy's FTO-9 facility in Visakhapatnam, Andhra Pradesh on October 8-9, 2026.
- The inspection resulted in a Form 483 with three observations.
- Dr. Reddy's will address the observations within the stipulated timeline.
Financial Impact
No financial figures disclosed; three Form 483 observations are routine and typically do not result in material financial impact unless escalated.
Risk Factors
- Potential escalation of Form 483 observations to a Warning Letter or import alert if not adequately addressed.
- Possible delays in product approvals tied to the FTO-9 facility.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001575872-26-000700 |
| Document: 0001575872-26-000700-index.html | 0001575872-26-000700 |
| Document: 0001575872-26-000700.txt | 0001575872-26-000700 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | 6-K | $13.65 | awaiting T+5 | — | $13.76 (+0.77%) |
Oct 26, 2026 1d ago | 6-K | $13.65 | awaiting T+5 | — | $13.76 (+0.77%) |
Oct 23, 2026 4d ago | 6-K | $13.21 | awaiting T+5 | — | $13.76 (−4.13%) |
Oct 23, 2026 4d ago | 6-K | $13.21 | awaiting T+5 | — | $13.76 (+4.13%) |
Oct 23, 2026 4d ago | 6-K | $13.21 | awaiting T+5 | — | $13.76 (+4.13%) |
Oct 23, 2026 4d ago | 6-K | $13.21 | awaiting T+5 | — | $13.76 (−4.13%) |
Oct 21, 2026 6d ago | 6-K | $13.19 | awaiting T+5 | — | $13.76 (+4.28%) |
Oct 14, 2026 13d ago | 6-K | $12.75 $13.19 | ▲ +3.45% | ▲ +3.00% | $13.76 (+7.88%) |
Oct 8, 2026 19d ago | 6-K | $12.20 $12.90 | ▲ +5.74% | ▲ +6.01% | $13.76 (+12.75%) |
Oct 7, 2026 20d ago | 6-K | $12.27 $12.75 | ▲ +3.91% | ▲ +4.89% | $13.76 (+12.10%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers